These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6190882)

  • 81. Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis.
    Chambers D; Scott F; Bangur R; Davies R; Lim A; Walters S; Smith G; Pitt T; Stableforth D; Honeybourne D
    Eur Respir J; 2005 Oct; 26(4):651-6. PubMed ID: 16204596
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Characterization of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients by different typing methods.
    Hafiane A; Ravaoarinoro M
    Pathol Biol (Paris); 2011 Oct; 59(5):e109-14. PubMed ID: 19896303
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
    Jain K; Wainwright C; Smyth AR
    Cochrane Database Syst Rev; 2013 Dec; (12):CD009530. PubMed ID: 24363033
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center.
    Lee TW; Brownlee KG; Denton M; Littlewood JM; Conway SP
    Pediatr Pulmonol; 2004 Feb; 37(2):104-10. PubMed ID: 14730654
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.
    Isles A; Maclusky I; Corey M; Gold R; Prober C; Fleming P; Levison H
    J Pediatr; 1984 Feb; 104(2):206-10. PubMed ID: 6420530
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa.
    McCallum SJ; Corkill J; Gallagher M; Ledson MJ; Hart CA; Walshaw MJ
    Lancet; 2001 Aug; 358(9281):558-60. PubMed ID: 11520530
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis and the possible role of contamination by dental equipment.
    Jensen ET; Giwercman B; Ojeniyi B; Bangsborg JM; Hansen A; Koch C; Fiehn NE; Høiby N
    J Hosp Infect; 1997 Jun; 36(2):117-22. PubMed ID: 9211158
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Lack of association between clinical and environmental isolates of Pseudomonas aeruginosa in hospital wards.
    Orsi GB; Mansi A; Tomao P; Chiarini F; Visca P
    J Hosp Infect; 1994 May; 27(1):49-60. PubMed ID: 7916363
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Fecal isolation of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Agnarsson U; Glass S; Govan JR
    J Clin Microbiol; 1989 Jan; 27(1):96-8. PubMed ID: 2492306
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients.
    Høiby N; Pedersen SS
    Antibiot Chemother (1971); 1989; 42():124-9. PubMed ID: 2596835
    [No Abstract]   [Full Text] [Related]  

  • 91. [Characteristics of sources and means of spread of Pseudomonas aeruginosa infections in urology wards].
    Zueva LP; Iafaev RKh; Ganeeva NF; Arkhangel'skiĭ AI; Reznikov LIa
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Feb; (2):61-4. PubMed ID: 2499142
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Survival of cystic fibrosis patients in South Australia. Evidence that cystic fibrosis centre care leads to better survival.
    Hill DJ; Martin AJ; Davidson GP; Smith GS
    Med J Aust; 1985 Sep; 143(6):230-2. PubMed ID: 4033505
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Pseudomonads as a marker of the sanitary-epidemiological state of maternity institutions].
    Stavertiĭ LV; Mefod'ev VV; Gileva SV
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (2):42-5. PubMed ID: 7653135
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Flow volume curves in children with cystic fibrosis--a possible risk of cross-infection?
    Marchant JL; Little SA; Bush A
    Respir Med; 1994 Mar; 88(3):235-6. PubMed ID: 8209073
    [No Abstract]   [Full Text] [Related]  

  • 95. Cross-colonization and routes of infection assessed with a DNA probe.
    Botzenhart K; Wolz C; Döring G
    Antibiot Chemother (1971); 1991; 44():8-12. PubMed ID: 1801648
    [No Abstract]   [Full Text] [Related]  

  • 96. The laryngoscope as a potential source of cross-infection.
    Foweraker JE
    J Hosp Infect; 1995 Apr; 29(4):315-6. PubMed ID: 7658015
    [No Abstract]   [Full Text] [Related]  

  • 97. Investigation of hospital infection from a damaged mattress and the demonstration of its mechanism.
    Lilly HA; Kidson A; Fujita K
    Burns Incl Therm Inj; 1982 Jul; 8(6):408-13. PubMed ID: 6809231
    [No Abstract]   [Full Text] [Related]  

  • 98. Who's at The Door? - Surface Contamination of Door Frames in a Single-Bedded In-Patient Adult Cystic Fibrosis (CF) Unit.
    Furukawa M; McCaughan J; Stirling J; Millar BC; Addy C; Caskey S; Goldsmith CE; Rendall JC; Misawa N; Downey DG; Moore JE
    Ulster Med J; 2020 Jan; 89(1):17-20. PubMed ID: 32218622
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Halting the spread of epidemic pseudomonas aeruginosa in an adult cystic fibrosis centre: a prospective cohort study.
    Ashish A; Shaw M; Winstanley C; Humphreys L; Walshaw MJ
    JRSM Short Rep; 2013 Jan; 4(1):1. PubMed ID: 23413403
    [TBL] [Abstract][Full Text] [Related]  

  • 100. 'Be afraid - be very afraid': passive air drying of nebulizer parts in cystic fibrosis - occult microbiological risks of contamination with Pseudomonas aeruginosa from calyptrate flies (Musca domestica and Calliphora vomitoria).
    Moore JE; Millar BC
    J Hosp Infect; 2022 May; 123():193-194. PubMed ID: 35247495
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.